Philadelphia-chromosome positive (Ph+) ALL is characterized by the presence of reciprocal translocation t(9;22)(q34;q11), leading to BCR-ABL fusion gene encoding BCR-ABL oncoprotein, that has constitutive tyrosine kinase activity and plays a central role in ALL development [3,4]. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.